CLINICAL_TRIALS
trial_result
· 2013-10-14
Clinical Trial Update: Lurasidone HCI - A 6-week Phase 3 Study of Patients With Bipolar I Depression [Phase 3]
Summary
A Phase 3 trial of lurasidone HCl for Bipolar I Depression has completed, and the results were posted in October 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sumitomo Pharma America, Inc. | Conditions: Bipolar Depression | Phase 3 | Status: COMPLETED | Results posted: 2013-10-14